Dr. Reddy’s Lab Launches Prostrate Cancer Drug in India

Dr. Reddy’s Laboratories Ltd has launched PamorelinÒ LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland.

PamorelinÒ LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer. It will be imported in bulk from Debio Recherche Pharmaceutique (Debio R.P.) and made available primarily to urologists and oncologists across India.